तोंडाचा कर्करोग
This study involved people with oral cancer and looked at how well a new saliva-based testing device could tell if their treatment was working, if the cancer might come back, and how well they were recovering compared to the usual methods like biopsies and medical scans.
हॉस्पिटलशी संपर्क साधा
रजिस्ट्रीमध्ये या हॉस्पिटलला ट्रायलचा मुख्य संपर्क म्हणून दिलं आहे. कोणते हॉस्पिटल्स रुग्ण घेत आहेत, हे त्यांना विचारा.
रजिस्ट्री सारांश (तांत्रिक)
A Prospective, Multi-Centre, Performance Evaluation Study to Determine the Accuracy of Saliscope, A Saliva Based Companion Diagnostic Assay in Predicting Chemotherapeutic Response, Relapse Propensity and Immunotherapeutic Efficacy in Oral Squamous Cell Carcinoma Patients, in Comparison to Conventional Histopathology Evaluation and RECIST Guidelines - NIL
Sponsor: Genoscope Private Limited
CTRI/2026/06/112560 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
शेवटचं अपडेट 5 Oct 2026 · आम्ही वाचलं 5 Nov 2026